|A product of the Society of Infectious Diseases Pharmacists Education Center (SIDPEC)|
This activity will review a recent infectious disease journal article and critically evaluate study rationale and design, results, strengths/limitations of the research, and applicability of findings to clinical practice. This activity will be repeated on a quarterly basis with a focus on a different journal article and study design each time.
An open-access journal article will be selected for the activity, and a step-by-step discussion guide created by the faculty will be made accessible to participants. Participants are invited to read the article and review a downloadable discussion guide (as home-study) to consider faculty insights before completing an assessment for CE and/or BCIDP credit. A Twitter chat will be scheduled approximately 2 weeks after activity launch to facilitate additional discussion surrounding the selected article. Participation in the Twitter chat is optional (i.e. not required for CE and/or BCIDP credit) but encouraged to foster a thorough discussion of the article and key learning points.
The target audience for this activity includes pharmacists and board-certified infectious diseases pharmacists (BCIDPs) seeking to update their knowledge and skills related to contemporary infectious diseases literature review. At the completion of this activity, the participant will be able to:
- Describe study rationale and design as it relates to a recent infectious diseases journal article.
- Summarize the statistical methods used by the investigators, including a rationale for the methods selected.
- Assess study results to form a conclusion about primary and secondary outcomes.
- Determine the clinical applicability of study findings while considering strengths and limitations of the research.
Madeline King, PharmD, BCIDP
Assistant Professor of Clinical Pharmacy, Infectious Diseases
University of the Sciences, Philadelphia College of Pharmacy
Release Date: 02-03-2020
Expiration Date: 02-03-2023
This activity is jointly provided by ProCE, Inc. and the Society of Infectious Diseases Pharmacists. ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-20-007-H01-P has been assigned to this home study, knowledge-based activity. This activity is approved for 1.5 contact hour (0.15 CEU) in states that recognize ACPE providers. Participants must complete the online post-test and activity evaluation to receive pharmacy CE credit. No partial credit will be given. Statements of completion will be issued online at www.ProCE.com, and proof of completion will be posted in NABP CPE Monitor profiles.
The Society of Infectious Diseases Pharmacists (SIDP) is accredited by the Board of Pharmacy Specialties (BPS) as a provider of board certified infectious diseases pharmacist (BCIDP) credit. A BCIDP statement of credit will be issued online upon successful completion of a post-test and online evaluation. The post-test must be successfully completed in only one attempt. No partial credit will be given. BCIDP accreditation begins 02/03/2020 for this activity and is available for one year from this date.
It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation. Dr. King has served as a speaker for Tetraphase.
This activity is provided by ProCE, Inc. and SIDP.
The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.